Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Upd... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
     GlobeNewswire
    Full Story →

    Headline News
    Aileron Therapeutics Announces CEO Transition
    8:02a ET March 12 '24 GlobeNewswire
    Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
    4:05p ET February 15 '24 GlobeNewswire
    Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
    4:31p ET February 1 '24 GlobeNewswire
    More News →
    Day  0.84%Week  11.96%Month  24.03%More Charting →
    Today, 11:03a ET Tuesday April 23 '24. Markets Open.
    Last $4.71
    Day change   0.84%$0.04
    Open $4.74
    Gap at open $0.01
    Previous close $4.75
    Trading volume 7,601
    10 Day avg vol. 253,025
    Shares out. 17.0Mil
    Market cap. $79.9Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 22 '24.

    Historical Price Performance
    3 month   2.17% 
    6 month   286% 
    1 year   225% 
    2 year   56.60% 

    Earnings
    Previous 12m -$2.85
    Next 12m Estimate -$0.62
    P/E ratio 1.7x
    Revenue 0Mil

    Market data provided by News provided by